These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6468477)

  • 1. Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: clinical and pathophysiological implications.
    Hodler JE; Galeazzi RL; Frey B; Rudhardt M; Seiler AJ
    Eur J Clin Pharmacol; 1984; 26(5):609-12. PubMed ID: 6468477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal and intravenous cefoperazone kinetics during continuous ambulatory peritoneal dialysis.
    Keller E; Jansen A; Pelz K; Hoppe-Seyler G; Schollmeyer P
    Clin Pharmacol Ther; 1984 Feb; 35(2):208-13. PubMed ID: 6692648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of cefoperazone in end-stage renal failure patients on peritoneal dialysis].
    Okuda T; Katoh T; Takaichi K; Matsunaga H; Uchida S; Kurokawa K; Nihei H
    Jpn J Antibiot; 1986 Oct; 39(10):2775-9. PubMed ID: 3806960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Chin TW; Pancorbo S; Comty C
    Clin Exp Dial Apheresis; 1981; 5(4):391-7. PubMed ID: 7341025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis.
    Johnson CA; Zimmerman SW; Reitberg DP; Whall TJ; Leggett JE; Craig WA
    Antimicrob Agents Chemother; 1988 Jan; 32(1):51-6. PubMed ID: 3348613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Salahudeen AK; Wilkinson R; McAinsh J; Bateman DN
    Br J Clin Pharmacol; 1984 Sep; 18(3):457-60. PubMed ID: 6487486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations.
    Keller E; Reetze P; Schollmeyer P
    Clin Pharmacokinet; 1990 Feb; 18(2):104-17. PubMed ID: 2180611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
    Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin clearance by continuous ambulatory peritoneal dialysis.
    Hays DP; Primack WA; Abroms IF
    Drug Intell Clin Pharm; 1985 Jun; 19(6):429-31. PubMed ID: 4006737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
    Singlas E; Boutron HF; Merdjan H; Brocard JF; Pocheville M; Fries D
    Clin Pharmacol Ther; 1983 Sep; 34(3):403-7. PubMed ID: 6224624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED; Blair AD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
    Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.
    Arvidsson A; Alván G; Tranaeus A; Malmborg AS
    Eur J Clin Pharmacol; 1985; 28(3):333-7. PubMed ID: 4007038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Sica DA; Comstock T; Harford A; Eshelman F
    Eur J Clin Pharmacol; 1987; 32(6):587-91. PubMed ID: 3653228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.
    Somani P; Shapiro RS; Stockard H; Higgins JT
    Clin Pharmacol Ther; 1982 Jul; 32(1):113-21. PubMed ID: 7083725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple dose pharmacokinetics of intravenous acyclovir in patients on continuous ambulatory peritoneal dialysis.
    Boelaert J; Schurgers M; Daneels R; Van Landuyt HW; Weatherley BC
    J Antimicrob Chemother; 1987 Jul; 20(1):69-76. PubMed ID: 3624115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.